X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3396) 3396
Book Chapter (36) 36
Dissertation (20) 20
Conference Proceeding (7) 7
Publication (4) 4
Book Review (2) 2
Web Resource (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pioglitazone (3155) 3155
science & technology (2212) 2212
life sciences & biomedicine (2024) 2024
humans (1317) 1317
male (1108) 1108
animals (929) 929
female (738) 738
thiazolidinediones - therapeutic use (723) 723
hypoglycemic agents - therapeutic use (709) 709
diabetes (666) 666
diabetes mellitus, type 2 - drug therapy (658) 658
thiazolidinediones - pharmacology (621) 621
insulin resistance (599) 599
thiazolidinediones (596) 596
pharmacology & pharmacy (591) 591
middle aged (535) 535
type 2 diabetes (523) 523
endocrinology & metabolism (499) 499
hypoglycemic agents - pharmacology (483) 483
diabetes mellitus (473) 473
rosiglitazone (454) 454
rats (442) 442
insulin (389) 389
metformin (366) 366
aged (336) 336
adult (329) 329
mice (327) 327
thiazolidinediones - administration & dosage (307) 307
hypoglycemic agents - adverse effects (261) 261
hypoglycemic agents (257) 257
hypoglycemic agents - administration & dosage (257) 257
glucose (254) 254
ppar gamma - agonists (254) 254
inflammation (247) 247
thiazolidinediones - adverse effects (244) 244
treatment outcome (243) 243
risk factors (222) 222
drug therapy, combination (212) 212
diabetes mellitus, type 2 - blood (203) 203
blood glucose - metabolism (201) 201
rodents (193) 193
ppar gamma - metabolism (189) 189
cardiovascular system & cardiology (187) 187
care and treatment (186) 186
biochemistry & molecular biology (185) 185
research (182) 182
analysis (178) 178
drug therapy (178) 178
rats, wistar (177) 177
type 2 diabetes mellitus (170) 170
disease models, animal (169) 169
medicine (168) 168
metabolism (168) 168
diabetes mellitus, type 2 - complications (163) 163
neurosciences & neurology (161) 161
clinical trials (160) 160
gene expression (158) 158
medicine & public health (156) 156
neurosciences (156) 156
chemistry (154) 154
thiazoles - pharmacology (153) 153
physical sciences (152) 152
metformin - therapeutic use (150) 150
rats, sprague-dawley (150) 150
dose-response relationship, drug (147) 147
oxidative stress (145) 145
peroxisome proliferator-activated receptors (144) 144
general & internal medicine (143) 143
obesity (143) 143
medicine, research & experimental (139) 139
research & experimental medicine (138) 138
liver (137) 137
medicine, general & internal (137) 137
double-blind method (136) 136
drugs (135) 135
research article (135) 135
blood glucose - drug effects (134) 134
thiazolidinedione (134) 134
internal medicine (131) 131
proteins (131) 131
patients (130) 130
science & technology - other topics (130) 130
abridged index medicus (129) 129
insulin - blood (129) 129
lipids (127) 127
multidisciplinary sciences (127) 127
troglitazone (126) 126
cells, cultured (125) 125
diabetes therapy (123) 123
health aspects (123) 123
cardiac & cardiovascular systems (120) 120
pparγ (117) 117
science (117) 117
time factors (115) 115
cell biology (114) 114
mice, inbred c57bl (114) 114
studies (114) 114
body weight (111) 111
apoptosis (108) 108
diabetes mellitus, type 2 - metabolism (106) 106
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3337) 3337
Japanese (67) 67
German (35) 35
Chinese (23) 23
Korean (18) 18
French (16) 16
Spanish (14) 14
Portuguese (12) 12
Czech (5) 5
Persian (4) 4
Turkish (3) 3
Polish (2) 2
Dutch (1) 1
Hungarian (1) 1
Norwegian (1) 1
Russian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes (New York, N.Y.), ISSN 0012-1797, 06/2019, Volume 68, Issue Supplement 1, p. 223
Pioglitazone (PIO) therapy results in a ∼60% resolution of NASH in patients with prediabetes or T2DM. However, the effects of treatment discontinuation have... 
Pioglitazone
Journal Article
Tonyōbyō, ISSN 0021-437X, 2009, Volume 52, Issue 3, pp. 235 - 238
Journal Article
Cellular physiology and biochemistry, ISSN 1015-8987, 04/2018, Volume 45, Issue 6, pp. 2351 - 2368
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 05/2017, Volume 25, Issue 13, pp. 1549 - 1566
It is known that Cardiovascular (CV) disease is the leading cause of morbidity and mortality in individuals with type 2 diabetes. Over the last years, one of... 
Cardiovascular events | Pioglitazone | Sulfonylureas | Dipeptidyl peptidase-4 inhibitors | Glucagon-like peptide-1 receptor agonists | Metformin | Insulin | Sodium-glucose co-transporters-2 inhibitors | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Metformin - therapeutic use | Cardiovascular Diseases - drug therapy | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Pioglitazone - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Cardiovascular Diseases - complications | Glucagon-Like Peptides - pharmacology | Liraglutide - pharmacology | Glucosides - therapeutic use | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Insulin - pharmacology | Glucosides - pharmacology | Sodium-Glucose Transporter 2 - metabolism | Metformin - pharmacology | Pioglitazone - pharmacology | Hypoglycemic Agents - pharmacology | Liraglutide - therapeutic use | Benzhydryl Compounds - pharmacology | Glucagon-Like Peptides - therapeutic use | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Heart | Diabetes mellitus | Clinical trials | Diabetes | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Patients | Morbidity
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2016, Volume 374, Issue 14, pp. 1321 - 1331
Journal Article
Journal Article
Journal Article